Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Free Remission”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Study completedNCT01456351
What this trial is testing

Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
University of Giessen 230
Testing effectiveness (Phase 2)Study completedNCT01393405
What this trial is testing

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of North Carolina, Chapel Hill 179
Testing effectiveness (Phase 2)Looking for participantsNCT04838041
What this trial is testing

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia
Medical College of Wisconsin 51
Not applicableLooking for participantsNCT04769947
What this trial is testing

Italian Treatment Free Remission Registry

Who this might be right for
Treatment Free RemissionChronic Myeloid Leukemia
University of Turin, Italy 800
Testing effectiveness (Phase 2)Looking for participantsNCT04698785
What this trial is testing

Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

Who this might be right for
Bone SarcomaOsteosarcoma
Centre Leon Berard 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04971226
What this trial is testing

Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Who this might be right for
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals 405
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Post-approval studies (Phase 4)UnknownNCT02602314
What this trial is testing

Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia

Who this might be right for
Chronyc Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 450
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Early research (Phase 1)Looking for participantsNCT07651878
What this trial is testing

Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Mendus 24
Testing effectiveness (Phase 2)Study completedNCT02852486
What this trial is testing

Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response

Who this might be right for
Leukemia, Chronic Myeloid
University of Campinas, Brazil 31
Large-scale testing (Phase 3)Study completedNCT00074542
What this trial is testing

An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Tillotts Pharma AG 364
Not applicableEnded earlyNCT02485353
What this trial is testing

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Who this might be right for
Leukemia, Myeloid, Acute
Hamid Sayar 2
Post-approval studies (Phase 4)Study completedNCT02177071
What this trial is testing

A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy

Who this might be right for
Crohn's Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 211
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01784068
What this trial is testing

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 215
Testing effectiveness (Phase 2)Active Not RecruitingNCT03817398
What this trial is testing

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
Children's Oncology Group 110
Testing effectiveness (Phase 2)Study completedNCT01301820
What this trial is testing

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 120